glp-1 intestinal paralysis lawsuit in michigan receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Weight Loss Drugs Lawsuit |
Description
Healthy habits are free
Eur J Pharmacol 797:162172
10.1016/j.cmet.2017.02.008 116
doi: 10.1111/bcp.14538
This concern applies to any rapid weight loss method during breastfeeding, not just GLP-1 medications
